Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00446225 |
|---|---|
| Brief Title: | Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR (EURTAC) |
| First Submitted : | March 8, 2007 |
| First Submitted that Met QC Criteria : | March 9, 2007 |
| First Posted : | March 12, 2007 (Estimate) |
| Last Update Submitted that Met QC Criteria : | June 8, 2022 |
| Last Update Posted : | June 13, 2022 |